Skip to main content
Advertisement
Home

Main navigation

  • Digital Issue Archive
  • Service Directory
  • Awards
  • Advertise
  • Subscribe now

Secondary

  • Travel Insurance
  • Policies & Partnerships
  • Travel Risk Management
  • Travel Trends
  • International Medical Care
  • Industry Moves
  • Reviews

WHO says only 22% of countries have funded and implemented antimicrobial resistance plans

Travel Risk Management
21 Nov 2026 | Jake Meeus-Jones
Share
WHO says only 22% of countries have funded and implemented antimicrobial resistance plans

Much of the world remains off track to meet 2030 targets for comprehensive bacterial and fungal resistance testing, according to new WHO data

More countries are taking steps to tackle antimicrobial resistance, but major gaps remain in testing and treatment, leaving patients at risk, according to the World Health Organization (WHO).

Out of 183 countries that responded to the Global Database for Tracking AMR self-assessment survey, 173 reported having developed national action plans to address antimicrobial resistance (AMR), up from 79 in 2017.

But only 22% of the 183 countries reported having both the necessary funding and full implementation of their plans.

Dr Tedros Adhanom Ghebreyesus, WHO Director-General, said in a statement marking World AMR Awareness Week (18–24 November): “National plans are essential for protecting the medicines that protect us. But an unfulfilled plan helps no one. We call on all countries to implement their plans with investments in infection prevention, surveillance, equitable access to essential antimicrobials and quality diagnostics.”

In 2024, countries agreed to work towards a series of targets to be met by 2030 – one of which was to ensure that 80% of countries have comprehensive bacterial and fungal resistance testing capacity.

However, only 36% of countries reported having a national reference laboratory equipped to test selected bacteria and fungi. According to WHO, in 2023 approximately one in six laboratory-confirmed bacterial infections worldwide were resistant to antibiotics, highlighting the growing threat to patients.

Inadequate diagnostic capacity can result in patients receiving ineffective or unnecessary antibiotics, while resistant infections and outbreaks may go undetected.

The European Centre for Disease Prevention and Control (ECDC) has also warned that “urgent action” is needed to ensure antibiotics remain effective.

ECDC Director Pamela Rendi-Wagner said: “We are still behind with several of the EU’s 2030 targets to counter antimicrobial resistance. However, the good news is that we can now look beyond just numbers. Innovations such as faster genomic surveillance mean that we can now assess better and more rapidly how resistant bacteria spread and how they evade antibiotics.”

The findings also raise wider questions about how insurers and assistance providers manage infectious disease risks, particularly when coordinating medical care across borders.

Travel Risk Management
21 Nov 2026
Share

Jake Meeus-Jones

Jake Meeus-Jones is a Junior Editor/News Writer at Voyageur Group, joining the company in 2026. He writes for ITIJ, AirMed&Rescue, International Hospitals & Healthcare (IH&H), Air Ambulance Review, and Assistance & Repatriation Review. He has previously written stories across the healthcare, travel, money, politics, and human interest sectors. He holds a BA (Hons) in Broadcast Journalism, graduating from the University of the West of England.

Keep on reading

No results

There are no results available matching your search term.

Why subscribe to ITIJ?

In-depth analysis

In-depth analysis

Unique insights and expert opinions on the latest industry developments

A wider perspective

A wider perspective

Get the global view on the topics that are trending in your region

Breaking news

Breaking news

ITIJ.com has all the latest news relevant to travel insurance and IPMI professionals

Subscribe now
ITIJ IH&H

Footer menu

  • About Us
  • Subscribe
  • Advertise
  • Contact
  • Privacy Policy
  • Terms
  • Voyageur
International Travel & Health Insurance Conferences

Social

  • LinkedIn link
  • Twitter link

© Voyageur Publishing & Events 2026

Close